Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

11,908 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Successful treatment of young childhood standard-risk hepatoblastoma with cisplatin monotherapy using a central review system.
Saeki I, Ida K, Kurihara S, Watanabe K, Mori M, Hishiki T, Yokoi A, Fujimura J, Honda S, Nogami Y, Iehara T, Kazama T, Sekiguchi M, Kitagawa N, Matsumura R, Nomura M, Yamada Y, Hanaki R, Kaneda H, Takama Y, Inoue T, Tanaka Y, Miyazaki O, Nagase H, Takimoto T, Yoshimura K, Hiyama E. Saeki I, et al. Among authors: inoue t. Pediatr Blood Cancer. 2024 Nov;71(11):e31255. doi: 10.1002/pbc.31255. Epub 2024 Aug 10. Pediatr Blood Cancer. 2024. PMID: 39126361
Consensus classification of pediatric hepatocellular tumors: A report from the Children's Hepatic tumors International Collaboration (CHIC).
Cho SJ, Ranganathan S, Alaggio R, Maibach R, Tanaka Y, Inoue T, Leuschner I, de Krijger R, Vokuhl C, Krailo M, Malogolowkin M, Meyers R, Czauderna P, Hiyama E, Ansari M, Morland B, Trobaugh-Lotrario A, O'Neill AF, Rangaswami A, Häberle B, López-Terrada D. Cho SJ, et al. Among authors: inoue t. Pediatr Blood Cancer. 2023 Jun 29:e30505. doi: 10.1002/pbc.30505. Online ahead of print. Pediatr Blood Cancer. 2023. PMID: 37384428
Upfront or delayed surgery in resectable hepatoblastoma: analysis from the children's hepatic tumors international collaboration database.
Hiyama E, Hishiki T, Yoshimura K, Krailo M, Maibach R, Haeberle B, Rangaswami A, Lopez-Terrada D, Malogolowkin MH, Ansari M, Alaggio R, O'Neill AF, Trobaugh-Lotrario AD, Watanabe K, Schmid I, Ranganathan S, Tanaka Y, Inoue T, Piao J, Lin J, Czauderna P, Meyers RL, Aronson DC. Hiyama E, et al. Among authors: inoue t. EClinicalMedicine. 2024 Sep 9;76:102811. doi: 10.1016/j.eclinm.2024.102811. eCollection 2024 Oct. EClinicalMedicine. 2024. PMID: 39309724 Free PMC article.
Subtyping of Group 3/4 medulloblastoma as a potential prognostic biomarker among patients treated with reduced dose of craniospinal irradiation: a Japanese Pediatric Molecular Neuro-Oncology Group study.
Fukuoka K, Kurihara J, Shofuda T, Kagawa N, Yamasaki K, Ando R, Ishida J, Kanamori M, Kawamura A, Park YS, Kiyotani C, Akai T, Keino D, Miyairi Y, Sasaki A, Hirato J, Inoue T, Nakazawa A, Koh K, Nishikawa R, Date I, Nagane M, Ichimura K, Kanemura Y. Fukuoka K, et al. Among authors: inoue t. Acta Neuropathol Commun. 2023 Sep 25;11(1):153. doi: 10.1186/s40478-023-01652-4. Acta Neuropathol Commun. 2023. PMID: 37749662 Free PMC article.
TCF3::BEND2 in paediatric supratentorial tumour with carcinoma-like epithelial features classifying as MN1-altered astroblastoma by DNA methylation profiling.
Nakano Y, Nobusawa S, Sato-Otsubo A, Nakashima T, Suzuki H, Yamasaki K, Shirakura T, Inoue T, Okuno T, Kato M, Ichimura K, Sakamoto H. Nakano Y, et al. Among authors: inoue t. Neuropathol Appl Neurobiol. 2024 Oct;50(5):e13011. doi: 10.1111/nan.13011. Neuropathol Appl Neurobiol. 2024. PMID: 39434489 No abstract available.
A case report of odonto-hypophosphatasia with a novel variant in the ALPL gene.
Oto Y, Suzuki D, Morita T, Inoue T, Nitta A, Murakami N, Abe Y, Hamada Y, Akiyama T, Matsubara T. Oto Y, et al. Among authors: inoue t. J Pediatr Endocrinol Metab. 2024 Feb 5;37(3):276-279. doi: 10.1515/jpem-2023-0549. Print 2024 Mar 25. J Pediatr Endocrinol Metab. 2024. PMID: 38310522
First-line nivolumab plus platinum chemotherapy and bevacizumab for advanced nonsquamous non-small cell lung cancer: A 3-year follow-up of the phase 3 randomized TASUKI-52 trial.
Lee KH, Lee JS, Sugawara S, Kang JH, Kim HR, Inui N, Hida T, Yoshida T, Tanaka H, Yang CT, Inoue T, Nishio M, Ohe Y, Tamura T, Yamamoto N, Yu CJ, Akamatsu H, Takahashi S, Nakagawa K. Lee KH, et al. Among authors: inoue t. Lung Cancer. 2025 Jan 25;201:108109. doi: 10.1016/j.lungcan.2025.108109. Online ahead of print. Lung Cancer. 2025. PMID: 39893774 Free article.
11,908 results
You have reached the last available page of results. Please see the User Guide for more information.